Not logged in | Create account | Login
    Menu

      Authorpædia Trademarks

      Social buttons

      Languages

      Read

      AUTHORPÆDIA is hosted by Authorpædia Foundation, Inc. a U.S. non-profit organization.

    Svetlana Velmar-Janković

    ALPHA
    Clinical data
    Other names3,4-Methylenedioxy-α-ethylbenzylamine; 1-Amino-1-(3,4-methylenedioxyphenyl)propane
    Routes of
    administration    		Oral[1]
    Drug classUnknown[1]
    ATC code
    • None
    Pharmacokinetic data
    Duration of action~3 hours[1]
    Identifiers
    • 1-(1,3-Benzodioxol-5-yl)propan-1-amine
    CAS Number
    PubChem CID
    ChemSpider
    UNII
    CompTox Dashboard (EPA)
    Chemical and physical data
    FormulaC10H13NO2
    Molar mass179.219 g·mol−1
    3D model (JSmol)
    • CCC(N)c1ccc2OCOc2c1
    • InChI=1S/C10H13NO2/c1-2-8(11)7-3-4-9-10(5-7)13-6-12-9/h3-5,8H,2,6,11H2,1H3 checkY
    • Key:VEOUOCLRLNJOLJ-UHFFFAOYSA-N checkY
      (verify)

    ALPHA, also known as 3,4-methylenedioxy-α-ethylbenzylamine, is a psychoactive drug of the substituted benzylamine group and a positional isomer of 3,4-methylenedioxyamphetamine (MDA).[1][2] It is also a benzylamine analogue of 3,4-methylenedioxyamphetamine (MDA).[1][2] ALPHA was first synthesized by Alexander Shulgin.[1][2] In his book PIHKAL on the MDA page, the threshold dosage is listed as 10 mg.[1] At mild threshold dosages (around 10 mg) there are eyes-closed "dreams" with some body tingling, at higher doses (up to 140 mg) was reported to produce a pleasant, positive feeling.[1] This compound is not anoretic at any dose.[1] Its duration is about 3 hours.[1] Very little data exists about the pharmacological properties, metabolism, and toxicity of ALPHA.[1][2] The drug was encountered as a novel designer drug by 1996.[3][4]

    See also

    References

    1. ^ a b c d e f g h i j k MDA Entry in PIHKAL
    2. ^ a b c d Shulgin A, Manning T, Daley PF (2011). The Shulgin Index, Volume One: Psychedelic Phenethylamines and Related Compounds. Vol. 1. Berkeley: Transform Press. ISBN 978-0-9630096-3-0.
    3. ^ King L, Poortman-van der Meer A, Huizer H (1996). "1-Phenylethylamines: a new series of illicit drugs?". Forensic Science International. 77 (3): 141–149. doi:10.1016/0379-0738(95)01852-2. Retrieved 9 April 2025.
    4. ^ King LA (1996). "Designer drugs related to amphetamine (1990-1996)". Journal of the Clandestine Laboratory Investigating Chemists Association. 6 (3): 15–16.


    Credit: Wikipedia https://en.wikipedia.org/wiki/ALPHA_(drug)

    Explore other authors